- Home
- DVAX vs CRON Comparison
DVAX vs CRON Comparison
Compare DVAX & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- CRON
- Stock Information
- Founded
- DVAX 1996
- CRON N/A
- Country
- DVAX United States
- CRON Canada
- Employees
- DVAX N/A
- CRON N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- CRON Medicinal Chemicals and Botanical Products
- Sector
- DVAX Health Care
- CRON Health Care
- Exchange
- DVAX Nasdaq
- CRON Nasdaq
- Market Cap
- DVAX 1.2B
- CRON 961.2M
- IPO Year
- DVAX 2004
- CRON N/A
- Fundamental
- Price
- DVAX $11.21
- CRON $2.45
- Analyst Decision
- DVAX Buy
- CRON
- Analyst Count
- DVAX 4
- CRON 0
- Target Price
- DVAX $26.50
- CRON N/A
- AVG Volume (30 Days)
- DVAX 1.7M
- CRON 1.3M
- Earning Date
- DVAX 11-05-2025
- CRON 11-06-2025
- Dividend Yield
- DVAX N/A
- CRON N/A
- EPS Growth
- DVAX N/A
- CRON N/A
- EPS
- DVAX N/A
- CRON 0.09
- Revenue
- DVAX $330,514,000.00
- CRON $132,357,000.00
- Revenue This Year
- DVAX $23.23
- CRON $19.67
- Revenue Next Year
- DVAX $16.57
- CRON $30.56
- P/E Ratio
- DVAX N/A
- CRON $26.10
- Revenue Growth
- DVAX 26.73
- CRON 19.00
- 52 Week Low
- DVAX $9.20
- CRON $1.60
- 52 Week High
- DVAX $14.63
- CRON $3.16
- Technical
- Relative Strength Index (RSI)
- DVAX 64.07
- CRON 45.55
- Support Level
- DVAX $10.97
- CRON $2.43
- Resistance Level
- DVAX $11.43
- CRON $2.58
- Average True Range (ATR)
- DVAX 0.36
- CRON 0.08
- MACD
- DVAX 0.07
- CRON -0.00
- Stochastic Oscillator
- DVAX 86.42
- CRON 16.67
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.